SEC Form 4 · accession 0001179110-17-002991
Theravance Biopharma, Inc. · TBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Junning Lee
Officer — Sr. VP, Technical Operations
Period of report
Feb 20, 2017
Accepted (ET)
Feb 22, 2017 · 7:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583107
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Feb 20, 2017 | F | 9,611 | $33.78 | D | 225,071 | D | |
| Ordinary SharesF1 | holding | — | — | — | 9,000 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1By Spouse as holder of self directed retirement account. Reporting person disclaims beneficial ownership of these securities in excess of his pecuniary interest therein.